GenMark Diagnostics

GenMark Diagnostics is a leading provider of automated, multiplex molecular diagnostic testing systems. Utilizing GenMark's proprietary eSensor detection technology, GenMark's eSensor XT-8 system and ePlex sample-to-answer systems are designed to support a broad range of molecular diagnostic tests with a compact, easy-to-use workstation and self-contained, disposable test cartridges. At GenMark, we’re changing the diagnostics landscape, combining out-of-the-box thinkers and game-changing technology to revolutionize patient care. Our work atmosphere is dynamic, fast-paced, and patient-focused. We encourage teamwork, while reinforcing the importance of individuality, and encouraging an entrepreneurial spirit. GenMark is not just a job – it’s a way of life. We also provide opportunities to volunteer in the community, participate in sports leagues, and enjoy company social events. Culture is the cornerstone of what makes GenMark a special place to work. We are proud to embrace a culture of accountability in the work we do.
Company Growth (employees)
Type
Public
HQ
Carlsbad, US
Founded
2010
Size (employees)
308 (est)+33%
GenMark Diagnostics was founded in 2010 and is headquartered in Carlsbad, US

GenMark Diagnostics Office Locations

GenMark Diagnostics has offices in Carlsbad, Englewood, Chicago, Minneapolis and in 30 other locations
Carlsbad, US (HQ)
5964 La Pl Ct
Zug, CH
6 General Guisan Strasse

GenMark Diagnostics Data and Metrics

GenMark Diagnostics Financial Metrics

GenMark Diagnostics's revenue was reported to be $49.3 m in FY, 2016 which is a 25% increase from the previous period.
USD

Revenue (FY, 2016)

49.3 m

Revenue growth (FY, 2015 - FY, 2016), %

25%

Gross profit (FY, 2016)

29.6 m

Gross profit margin (FY, 2016), %

60%

Net income (FY, 2016)

(50.6 m)

EBIT (FY, 2016)

(49 m)

Market capitalization (26-Jun-2017)

592.8 m

Closing share price (26-Jun-2017)

12.8

Cash (31-Dec-2016)

16 m
GenMark Diagnostics's current market capitalization is $592.8 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

27.4 m30.6 m39.4 m49.3 m

Revenue growth, %

12%29%25%

Cost of goods sold

15.3 m19.7 m

Gross profit

11.5 m17.5 m24.1 m29.6 m

Gross profit Margin, %

42%57%61%60%

Operating expense total

46.4 m56.5 m65.6 m78.6 m

EBIT

(34.9 m)(39.1 m)(41.5 m)(49 m)

EBIT margin, %

(127%)(128%)(105%)(99%)

Interest expense

880 k1.5 m

Interest income

125 k176 k

Pre tax profit

(42.2 m)(50.5 m)

Income tax expense

40 k100 k

Net Income

(33.6 m)(38.3 m)(42.2 m)(50.6 m)
USDY, 2009Y, 2010Y, 2011Y, 2012Y, 2013Y, 2014Y, 2015FY, 2016

Cash

16.5 m51.3 m25.3 m51.3 m35.7 m36.9 m35.4 m16 m

Inventories

2.1 m2.1 m3.1 m3.1 m

Current Assets

111.1 m78.1 m56 m58.4 m

PP&E

8.6 m11.1 m11.4 m18.3 m

Total Assets

121.8 m92 m70.7 m80.3 m

Accounts Payable

3.9 m3.5 m4.4 m4.4 m

Current Liabilities

10.2 m12.3 m10.6 m26.4 m

Additional Paid-in Capital

333.4 m340.5 m353.2 m393.3 m

Retained Earnings

(224.2 m)(262.5 m)(304.7 m)(355.3 m)

Total Equity

48.6 m38.2 m

Financial Leverage

1.5 x2.1 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(33.6 m)(38.3 m)(42.2 m)(50.6 m)

Depreciation and Amortization

2.5 m2.7 m3.4 m3.9 m

Accounts Receivable

(2.4 m)(2 m)(2.3 m)(2.3 m)

Inventories

(1.3 m)(229 k)(3.5 m)(3.5 m)

Accounts Payable

1.3 m85 k4.1 m4.1 m

Cash From Operating Activities

(23.8 m)(29.6 m)(31.9 m)(35.6 m)

Purchases of PP&E

(4.3 m)(5.7 m)(3.8 m)(7 m)

Cash From Investing Activities

(72.6 m)29.4 m19.3 m(24.1 m)

Cash From Financing Activities

80.8 m1.3 m11.1 m40.4 m

Interest Paid

19 k20 k572 k1.1 m

Income Taxes Paid

21 k24 k10 k65 k
Y, 2016

Financial Leverage

2.1 x

GenMark Diagnostics Operating Metrics

FY, 2014FY, 2015FY, 2016

Patents Pending

253530

Patents Issued

130120100

GenMark Diagnostics Market Value History

GenMark Diagnostics Job Categories

GenMark Diagnostics Company Life and Culture

You may also be interested in